Related Experiment Video

Updated: Aug 18, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

The effect of Toremifene on the expression of some genes in human mononuclear cells

J A Kellen1

  • 1Sunnybrook Health Science Centre, Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.

In Vivo (Athens, Greece)
|May 1, 1995
PubMed

Insights

Toremifene alters gene expression in human immune cells, affecting key proteins like P-glycoprotein and steroid receptors. Long-term studies are recommended due to its use in cancer therapy.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • Antiestrogens, such as toremifene, are increasingly utilized in cancer treatment and prevention strategies.
  • Understanding the molecular effects of these drugs on non-cancerous cells is crucial for assessing their overall impact and safety profile.

Purpose of the Study:

  • To investigate the effects of toremifene on the gene expression of human peripheral mononuclear cells (PBMCs).
  • To identify specific molecular targets and pathways affected by short-term, in vitro exposure to therapeutic concentrations of toremifene.

Main Methods:

  • Human peripheral mononuclear cells were exposed in vitro to therapeutic levels of toremifene.
  • Gene expression analysis was performed to assess changes in specific protein levels.

Main Results:

  • Toremifene exposure led to distinct alterations in the expression of P-glycoprotein.
  • Changes were also observed in the expression of steroid receptors, p53, and Bcl-2.
  • These findings indicate a significant impact of toremifene on cellular machinery within PBMCs.

Conclusions:

  • Short-term in vitro exposure to toremifene significantly modulates gene expression in human PBMCs.
  • The observed changes in key proteins suggest potential broader biological effects beyond its antiestrogenic activity.
  • Further long-term in vivo studies are warranted to fully elucidate the implications of toremifene's effects in the context of cancer therapy and prevention.

More Related Videos

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...